|
KMID : 0358419940370050956
|
|
Korean Journal of Obstetrics and Gynecology
1994 Volume.37 No. 5 p.956 ~ p.964
|
|
|
Clinical Analysis and Treatment Results of 414 cases of Uterine Cervical Cancer
|
|
최광엽
김승철/박정은/고용석/최도형/신면우
|
|
|
Abstract
|
|
|
|
414 cases of uterine cervical cancer, diagnosed and treated from march 1989 to march 1993, were evaluated at Jung-Ang Gils general hospital, Incheon, Korea. The purpose of this study was to analyze the clinical profile and survival rate of cervical cancer. The number of patients were 67 cases in 1989, 88 cases in 1990, 90 cases in 1991, 139 cases in 1992 and 30 cases in 1993. The age distribution of patients were similar in the age group of 50s (25.6%), 40s (24.5%) and 30s (24.2%). The distriution of patients by the clinical stage were as follows: Stage 0, 57 cases (13.7%); Stage 1,207 cases (50.0%); Stage II, 103 cases (24.9%); Stage III, 35 cases (8.5%); and Stage IV, 12 cases (2.9%). The histopathologic types were as follows:Squamous cell carcinoma was 96.6%, adenocarcinoma was 2.9% and adenosquamous cell carcinoma was 0.5%. The frequency of pelvic lymph node metastasis was 3.7% in stage Ia, 16.9% in stage Ib and 19.6% in stage IIa. The incidence of pelvic node metastasis correlated with the size of the tumor, in stage Ib, was 10.5% for tumors less than 2 cm in diageter, 20.5% for tumors 2 to 4 cm, and 35.7% for tumors up to 4 cm. In stage IIa, the incidence was 10.0% for tumors less than 2 cm, 14.3% for tumors 2 to 4 cm, and 62.5% for tumors up to 4 cm. We have evaluated the survival rate by life table method for stage Ia and Ib, and by Kaplan-Meier method for stage IIa, Iib and III> The results were as follows; 100% 52 month survival rate for stage Ia; 91.7% 52 month survival for stage Ib; 96.7% 45 month survival for stage IIa; 58.9% 49 month survival for stage IIb; 42.9% 52 month survival for stage III.
|
|
|
KEYWORD
|
|
|
Uterine cervical cancer, metastasis, survival rate
|
|
|
FullTexts / Linksout information
|
|
 
|
|
|
Listed journal information
|
|
  
|
|